Clinical Trial

Integrative Analysis of Large-cell Lung Cancer

Study acronym: LCLC
Recruiting
View on ClinicalTrials.gov →
Summary
Integrative analysis of LCLC
Trial Details
NCT Number NCT02917369
Lead Sponsor Shanghai 10th People's Hospital
Collaborators: Shanghai Pulmonary Hospital, Shanghai, China
Conditions Lung Cancer
Enrollment 1,000 participants
Start Date 2016-01
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2016-09-28